US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class I · High risk Ongoing

FentaNYL citrate PF

Reason Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.

Denver Solutions, LLC DBA Leiters Health NDC 71449-072-41 D-0277-2024
Class II · Moderate risk Ongoing

Quality Choice No Drip Severe Congestion Nasal Pump Mist

Reason CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Seaway Pharma Inc. NDC 63868-608-01 D-0217-2024
Class II · Moderate risk Ongoing

Quality Choice No Drip Extra Moisturizing Nasal Pump Mist…

Reason CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Seaway Pharma Inc. NDC 63868-676-01 D-0216-2024
Class II · Moderate risk Ongoing

Premier Value Tussin Cough DM

Reason CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Seaway Pharma Inc. D-0215-2024
Class II · Moderate risk Ongoing

Nasal Spray Original No Drip Oxymetazoline HCl Nasal Solution

Reason CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Seaway Pharma Inc. NDC 63868-607-01 D-0214-2024
Class III · Low risk Ongoing

Benzonatate Capsules

Reason Superpotent drug: Assay results were slightly above specification at the time zero point.

Amerisource Health Services LLC NDC 68084-214-01 D-0257-2024
Class I · High risk Ongoing

Bleomycin for Injection

Reason Presence of particulate matter: glass

Pfizer NDC 61703-332-18 D-0261-2024
Class I · High risk Completed

Americaine

Reason Chemical Contamination: presence of benzene

Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company NDC 63736-378-02 D-0236-2024
Class I · High risk Ongoing

Atropine Sulfate Injection

Reason Presence of Particulate Matter; identified as glass

Pfizer Inc. NDC 0409-4911-11 D-0235-2024
Class I · High risk Ongoing

8.4 % Sodium Bicarbonate Injection

Reason Presence of Particulate Matter; identified as glass

Pfizer Inc. NDC 0409-6637-24 D-0234-2024
Class I · High risk Ongoing

4.2% Sodium Bicarbonate Injection

Reason Presence of Particulate Matter; identified as glass

Pfizer Inc. NDC 0409-5534-24 D-0233-2024
Class II · Moderate risk Ongoing

Good Neighbor Pharmacy

Reason MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.

Pharma Nobis LLC NDC 46122-741-38 D-0227-2024
Class II · Moderate risk Terminated

Desloratadine Tablets USP 5mg a) 100 count

Reason CGMP Deviations: N-Nitroso Desloratadine impurity result exceeded the acceptable intake limit.

Lupin Pharmaceuticals Inc. NDC 68180-153-01 D-0221-2024
Class II · Moderate risk Terminated

Tacrolimus Capsules

Reason Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.

Dr. Reddy's Laboratories, Inc. NDC 55111-526-01 D-0219-2024
Class II · Moderate risk Ongoing

Selenium Sulfide 2.25% Shampoo

Reason CGMP Deviations: Stability data does not support expiry date.

Private Label Partners, Inc. NDC 42582-900-06 D-0152-2024
Class III · Low risk Terminated

Anoro Ellipta

Reason Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification

GlaxoSmithKline LLC NDC 0173-0869-10 D-0160-2024
Class II · Moderate risk Ongoing

Sertraline Tablets

Reason CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.

Legacy Pharmaceutical Packaging LLC NDC 68645-523-54 D-0205-2024